Disagreements about what worked and what didn’t against the biggest public health disaster in modern times have yet to be ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

"The whole COVID discussion turned into culture war dialogue, with one side saying, 'I believe in the economy and liberty,' ...

Her "simple request" of pharma companies "is simply to provide products." Only a handful of pharmaceutical compounds have ...

Faculty members share insights, expertise on the ramifications of a decline in federal support for science and research ...

Echoing these concerns, Congress recently urged NIH to expand RECOVER’s scope to address the full spectrum of long Covid symptoms and evaluate therapies for overlapping conditions such as ME/CFS.

Tabak led the NIH during part of the COVID-19 pandemic and faced scrutiny from congressional Republicans over federal grants provided to Manhattan-based nonprofit EcoHealth Alliance for bat ...

NIH funding cuts would mean universities would have to find ways to make cutbacks and could result in “massive layoffs” ...

One of Trump's top health-related nominees had an uncommon income source over the past two years: posting on social media.

The No. 2 in command at the National Institutes of Health (NIH), Dr. Lawrence A. Tabak, who served as acting director of the agency during the COVID-19 pandemic, has abruptly resigned. Tabak ...